"Coronary Restenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
Descriptor ID |
D023903
|
MeSH Number(s) |
C14.280.647.250.285.200 C14.907.585.250.285.200
|
Concept/Terms |
Coronary Restenosis- Coronary Restenosis
- Coronary Restenoses
- Restenoses, Coronary
- Restenosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Restenosis".
Below are MeSH descriptors whose meaning is more specific than "Coronary Restenosis".
This graph shows the total number of publications written about "Coronary Restenosis" by people in this website by year, and whether "Coronary Restenosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2004 | 1 | 1 | 2 |
2005 | 2 | 0 | 2 |
2006 | 1 | 2 | 3 |
2007 | 4 | 2 | 6 |
2008 | 1 | 3 | 4 |
2009 | 4 | 1 | 5 |
2010 | 0 | 1 | 1 |
2012 | 1 | 2 | 3 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2015 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study. J Endovasc Ther. 2021 02; 28(1):107-116.
-
Combinatorial therapy of sirolimus and heparin by nanocarrier inhibits restenosis after balloon angioplasty ex vivo. Nanomedicine (Lond). 2020 05; 15(12):1205-1220.
-
Iterative reconstruction improves detection of in-stent restenosis by high-pitch dual-source coronary CT angiography. Sci Rep. 2017 07 31; 7(1):6956.
-
Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis. J Cardiovasc Comput Tomogr. 2016 Sep-Oct; 10(5):377-83.
-
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. Circulation. 2016 Jan 12; 133(2):131-8.
-
Coronary In-Stent Restenosis: Assessment with Corrected Coronary Opacification Difference across Coronary Stents Measured with CT Angiography. Radiology. 2015 May; 275(2):403-12.
-
Meta-analysis of same versus different stent for drug-eluting stent restenosis. Am J Cardiol. 2014 Feb 15; 113(4):601-6.
-
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2013 Sep; 6(9):914-22.
-
Drug-eluting versus bare-metal coronary stents: where are we now? J Comp Eff Res. 2012 Nov; 1(6):501-8.
-
Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.